Efforts to develop vaccines for diseases which are mainly an issue in the developing world continue to be funded almost exclusively by philanthropy rather than pharmaceutical countries, says Visiting Policy Fellow Els Torreele (UCL Institute for Innovation & Public Purpose).
Close
